146 related articles for article (PubMed ID: 23564132)
1. Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure.
Gabrielian L; Helps SC; Thornton E; Turner RJ; Leonard AV; Vink R
Acta Neurochir Suppl; 2013; 118():201-4. PubMed ID: 23564132
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage.
Barry CM; Helps SC; den Heuvel Cv; Vink R
Brain Res; 2011 May; 1389():143-51. PubMed ID: 21377453
[TBL] [Abstract][Full Text] [Related]
3. A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.
Turner RJ; Helps SC; Thornton E; Vink R
Brain Res; 2011 Jun; 1393():84-90. PubMed ID: 21466790
[TBL] [Abstract][Full Text] [Related]
4. The effect of an NK1 receptor antagonist on blood spinal cord barrier permeability following balloon compression-induced spinal cord injury.
Leonard AV; Vink R
Acta Neurochir Suppl; 2013; 118():303-6. PubMed ID: 23564154
[TBL] [Abstract][Full Text] [Related]
5. Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
Donkin JJ; Nimmo AJ; Cernak I; Blumbergs PC; Vink R
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1388-98. PubMed ID: 19436311
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury.
Luh C; Kuhlmann CR; Ackermann B; Timaru-Kast R; Luhmann HJ; Behl C; Werner C; Engelhard K; Thal SC
J Neurochem; 2010 Feb; 112(4):1015-25. PubMed ID: 19943851
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments.
Donkin JJ; Vink R
Curr Opin Neurol; 2010 Jun; 23(3):293-9. PubMed ID: 20168229
[TBL] [Abstract][Full Text] [Related]
8. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats.
Turner RJ; Vink R
Neuroscience; 2012 Sep; 220():1-10. PubMed ID: 22750240
[TBL] [Abstract][Full Text] [Related]
9. Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.
Harford-Wright E; Lewis KM; Ghabriel MN; Vink R
PLoS One; 2014; 9(5):e97002. PubMed ID: 24818961
[TBL] [Abstract][Full Text] [Related]
10. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice.
Trabold R; Krieg S; Schöller K; Plesnila N
J Neurotrauma; 2008 Dec; 25(12):1459-65. PubMed ID: 19118456
[TBL] [Abstract][Full Text] [Related]
11. Substance P in traumatic brain injury.
Donkin JJ; Turner RJ; Hassan I; Vink R
Prog Brain Res; 2007; 161():97-109. PubMed ID: 17618972
[TBL] [Abstract][Full Text] [Related]
12. Magnesium enhances the beneficial effects of NK1 antagonist administration on blood-brain barrier permeability and motor outcome after traumatic brain injury.
Ameliorate JL; Ghabriel MN; Vink R
Magnes Res; 2017 Aug; 30(3):88-97. PubMed ID: 29256408
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema.
Papadopoulos MC; Manley GT; Krishna S; Verkman AS
FASEB J; 2004 Aug; 18(11):1291-3. PubMed ID: 15208268
[TBL] [Abstract][Full Text] [Related]
14. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats.
Nimmo AJ; Cernak I; Heath DL; Hu X; Bennett CJ; Vink R
Neuropeptides; 2004 Feb; 38(1):40-7. PubMed ID: 15003715
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
Turner R; Vink R
Timely Top Med Cardiovasc Dis; 2007 Oct; 11():E24. PubMed ID: 18297137
[TBL] [Abstract][Full Text] [Related]
16. Intracranial pressure changes following traumatic brain injury in rats: lack of significant change in the absence of mass lesions or hypoxia.
Gabrielian L; Willshire LW; Helps SC; van den Heuvel C; Mathias J; Vink R
J Neurotrauma; 2011 Oct; 28(10):2103-11. PubMed ID: 21657835
[TBL] [Abstract][Full Text] [Related]
17. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
Kleindienst A; Dunbar JG; Glisson R; Marmarou A
Acta Neurochir (Wien); 2013 Jan; 155(1):151-64. PubMed ID: 23188468
[TBL] [Abstract][Full Text] [Related]
18. Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours.
Lewis KM; Harford-Wright E; Vink R; Ghabriel MN
J Neuroimmunol; 2012 Sep; 250(1-2):59-65. PubMed ID: 22722013
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin in traumatic brain injury: effect on brain edema mechanisms.
Béziaud T; Ru Chen X; El Shafey N; Fréchou M; Teng F; Palmier B; Beray-Berthat V; Soustrat M; Margaill I; Plotkine M; Marchand-Leroux C; Besson VC
Crit Care Med; 2011 Oct; 39(10):2300-7. PubMed ID: 21666443
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary experience with controlled lumbar drainage in medically refractory intracranial hypertension].
Tömösvári A; Mencser Z; Futó J; Hortobágyi A; Bodosi M; Barzó P
Orv Hetil; 2005 Jan; 146(4):159-64. PubMed ID: 15751510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
